236 related articles for article (PubMed ID: 34979274)
21. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
22. Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells.
Zhang PF; Wang C; Zhang L; Li Q
Immunotherapy; 2022 Apr; 14(6):459-473. PubMed ID: 35232284
[TBL] [Abstract][Full Text] [Related]
23. Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers.
Arora S; Khan S; Zaki A; Tabassum G; Mohsin M; Bhutto HN; Ahmad T; Fatma T; Syed MA
Semin Cancer Biol; 2022 Nov; 86(Pt 2):720-736. PubMed ID: 35257861
[TBL] [Abstract][Full Text] [Related]
24. Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.
Vilgelm AE; Richmond A
Front Immunol; 2019; 10():333. PubMed ID: 30873179
[TBL] [Abstract][Full Text] [Related]
25. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.
Han ZJ; Li YB; Yang LX; Cheng HJ; Liu X; Chen H
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011369
[TBL] [Abstract][Full Text] [Related]
26. Chemokines in bone-metastatic breast cancer: Therapeutic opportunities.
Wang Y; Ren S; Wang Z; Wang Z; Zhu N; Cai D; Ye Z; Ruan J
Int Immunopharmacol; 2020 Oct; 87():106815. PubMed ID: 32711376
[TBL] [Abstract][Full Text] [Related]
27. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunity.
Yano H; Andrews LP; Workman CJ; Vignali DAA
Immunology; 2019 Jul; 157(3):232-247. PubMed ID: 31087644
[TBL] [Abstract][Full Text] [Related]
29. Clinical utilization of chemokines to combat cancer: the double-edged sword.
Dell'Agnola C; Biragyn A
Expert Rev Vaccines; 2007 Apr; 6(2):267-83. PubMed ID: 17408375
[TBL] [Abstract][Full Text] [Related]
30. Signaling-chemokine axis network in brain as a sanctuary site for metastasis.
Azizidoost S; Asnafi AA; Saki N
J Cell Physiol; 2019 Apr; 234(4):3376-3382. PubMed ID: 30187487
[TBL] [Abstract][Full Text] [Related]
31. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.
Marcuzzi E; Angioni R; Molon B; Calì B
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591657
[TBL] [Abstract][Full Text] [Related]
32. Chemokine receptor CXCR4: role in gastrointestinal cancer.
Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
[TBL] [Abstract][Full Text] [Related]
33. Chemokines in tumor immunotherapy.
Flanagan K; Kaufman HL
Front Biosci; 2006 Jan; 11():1024-30. PubMed ID: 16146794
[TBL] [Abstract][Full Text] [Related]
34. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
Mousavi A
Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
[TBL] [Abstract][Full Text] [Related]
35. The diverse role of chemokines in tumor progression: prospects for intervention (Review).
Schneider GP; Salcedo R; Welniak LA; Howard OM; Murphy WJ
Int J Mol Med; 2001 Sep; 8(3):235-44. PubMed ID: 11494048
[TBL] [Abstract][Full Text] [Related]
36. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
37. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.
Mortezaee K
Life Sci; 2020 May; 249():117534. PubMed ID: 32156548
[TBL] [Abstract][Full Text] [Related]
38. Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.
Rupertus K; Sinistra J; Scheuer C; Nickels RM; Schilling MK; Menger MD; Kollmar O
Clin Exp Metastasis; 2014 Apr; 31(4):447-59. PubMed ID: 24493023
[TBL] [Abstract][Full Text] [Related]
39. Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model.
Walser TC; Ma X; Kundu N; Dorsey R; Goloubeva O; Fulton AM
J Immunother; 2007; 30(5):490-8. PubMed ID: 17589289
[TBL] [Abstract][Full Text] [Related]
40. CXCL8 Signaling in the Tumor Microenvironment.
Asokan S; Bandapalli OR
Adv Exp Med Biol; 2021; 1302():25-39. PubMed ID: 34286439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
